Elita Poplavska
1Faculty Of Pharmacy, 16 Dzirciema Str
Riga, RIX 1007, Latvia
Riga, RIX 1007, Latvia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Implementation and use of risk minimization control tools in the EU: A multistakeholder survey.
Journal: British journal of clinical pharmacology
Published: June 22, 2026
Dispensing of benzodiazepines and benzodiazepine-related drugs in Estonia, Latvia and Lithuania: a cross-national drug utilisation study.
Journal: Nordic journal of psychiatry
Published: May 20, 2026
Perspectives on the impact of regulatory measures on national COVID-19 vaccination programs: a qualitative study from six EU member states.
Journal: Journal of pharmaceutical policy and practice
Published: November 06, 2025
The European medicines agency review of belzutifan (Welireg) for the treatment of adult patients with von Hippel-Lindau disease-associated tumors.
Journal: The oncologist
Published: July 17, 2025
Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: June 23, 2025
Letter to the editor re: fatal intracranial haemorrhage after belzutifan initiation.
Journal: ESMO open
Published: June 02, 2025
Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study.
Journal: Drug safety
Published: October 07, 2024
Latvian Healthcare Professionals' Self-Reported Knowledge, Attitudes, and Behaviors Related to Pregnancy Prevention Program Materials for Valproate-Containing Medicines.
Journal: Pharmacy (Basel, Switzerland)
Published: October 04, 2024
Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals.
Journal: Pharmacoepidemiology and drug safety
Published: January 23, 2024
Impact of Risk Minimisation Measures on Valproate Use among Women of Reproductive Age in Latvia Between 2013 and 2020: A 7-Year Nationwide Prescription Database Study.
Journal: Drugs - real world outcomes
Published: September 11, 2023
Last Updated: 09/26/2026